Port-a-cath-related Fusarium oxysporum infection in an HIV-infected patient: treatment with liposomal amphotericin B.
The first case of Port-a-cath-related disseminated fusariosis in an HIV-infected patient is presented. Antifungal treatment with liposomal amphotericin B (AmBisome) in a dose of 2 mg kg-1 day-1 for 14 days was successful.
Eljaschewitsch
J
J
Department of Infectious Disease, Virchow-Klinikum, Humboldt-University, Berlin, Germany.
Sandfort
J
J
Tintelnot
K
K
Horbach
I
I
Ruf
B
B
D017088:AIDS-Related Opportunistic Infections / Q000000981:diagnostic imaging / Q000188:drug therapy*; D000328:Adult; D000666:Amphotericin B / Q000008:administration & dosage / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002408:Catheters, Indwelling; D004337:Drug Carriers; D004866:Equipment Contamination; D005670:Fusarium; D015658:HIV Infections; D018451:Homosexuality, Male; D006801:Humans; D008081:Liposomes; D008297:Male; D009181:Mycoses / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000209:etiology; D014057:Tomography, X-Ray Computed
D000935:Antifungal Agents; D004337:Drug Carriers; D008081:Liposomes; D000666:Amphotericin B